Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking the MARS imaging system for its applications in medical diagnosis. 

The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.

Biotechnology

MARS Bioimaging Ltd

Org chart

Teams

Offices